---
title: p53 immunohistochemistry as an ancillary tool for rapid assessment of residual
  disease in TP53-mutated acute myeloid leukemia and myelodysplastic syndromes
date: '2024-04-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38643353/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240423181226&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: 'CONCLUSIONS: Our study suggests that p53 IHC can be used as a rapid
  tool (within 24 hours) to aid in the detection of residual disease that may complement
  MRD-FC or NGS in cases in which the flow cytometry immunophenotype is equivocal
  and/or the bone marrow aspirate is ...'
disable_comments: true
---
CONCLUSIONS: Our study suggests that p53 IHC can be used as a rapid tool (within 24 hours) to aid in the detection of residual disease that may complement MRD-FC or NGS in cases in which the flow cytometry immunophenotype is equivocal and/or the bone marrow aspirate is ...